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This paper examines the uses and limits of empirical data in evaluating measurement and
modeling approaches to human lead exposure. Empirical data from experiment or observation or
both have been used in studies of lead exposure. For example, experimental studies have
elucidated and quantified physiologic or biokinetic parameters of lead exposure under controlled
conditions. Observation, i.e., epidemiology, has been widely applied to study population exposures
to lead. There is growing interest in the use of lead exposure prediction models and their
evaluation before use in risk assessment. Empirical studies of lead exposure must be fully
understood, especially their limits, before they are applied as "standards" or reference information
for evaluation of exposure models, especially the U.S. Environmental Protection Agency's lead
biokinetic model that is a focus of this article. Empirical and modeled datasets for lead exposure
may not agree due to a) problems with the observational data or b) problems with the model;
caution should be exercised before either a model or observational data are rejected. There are at
least three sources of discordance in cases where there is lack of agreement: a) empirical data are
accurate but the model is flawed; b) the model is valid but reference empirical data are inaccurate;
or c) neither empirical data nor model is accurate, and each is inaccurate in different ways. This paper
evaluates some of the critical empirical inputs to biokinetic models, especially lead bioavailability.
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This paper describes uses and limits ofboth
empirical data and predictive exposure
models in assessing lead exposure; it was
prepared as part of the proceedings for a
U.S. Environmental Protection Agency
(U.S. EPA) meeting on lead biokinetic
models. The earlier portion is more concise
and summarizing, owing to the huge
amount ofdata. Some later sections are of
necessity more detailed because of the
evolving nature of the topics and their
importance, their current stage ofdevelop-
ment, and need for a current assessment.
Critical current assessment is particularly
required for the topic oflead bioavailabil-
ity, a significant element in reliable lead
exposure measurement and modeling. Lead
bioavailability in its many multidisciplinary
complexities and nuances is still poorly
understood and misunderstood by many, is
interpretively misused by others, and
continues to feed a growing, increasingly
jumbled literature. These differing tasks
involve different styles ofwriting on the
respective topics, differences the reader
hopefully will not find too abrupt in flow
ofthought and information.
Lead exposure in this paper refers to
both the amount oflead entering various
receiving compartments of the body
through inhalation and ingestion, and the
subsequent absorption ofsome fraction of
the lead intake. Intake is sometimes defined
by others as exposure, whereas the amount
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absorbed is defined as dose. There are
several ways one can attempt to quantitate
lead exposure in humans. One can measure
the amount oflead in biologic media from
these subjects or lead in environmental
media from their surroundings. One can
also estimate, i.e., predict, the extent oflead
exposure using a mathematical model and
available environmental lead or exposure
information, e.g., biologic data, for input.
As noted by Mushak (1), models are
abstract constructions and depictions of
complex systems that permit easier com-
prehension for study and application.
Biokinetic models ofsubstance uptake, dis-
position, and removal are the subject of
regulatory and health policy interest and
increasingly figure in risk assessment prac-
tices, per the guidelines of the National
Research Council (NRC) (2). The guide-
lines are categorized as hazard identifica-
tion, dose-response relationships, exposure
assessment, and risk characterization. The
first two are typically general or generic;
the remaining two are case- or site-specific.
In the case oflead, the first two compo-
nents are relatively well studied, but it is
the site-specific lead exposures that often
drive the utility of the overall paradigm.
Modeling oflead exposure in human pop-
ulations is especially useful in those situa-
tions where there are limits on field
measurements oflead exposure.
Models ofhuman lead exposure are of
various categorical and computational
types and they differ in their relative com-
plexityand range ofapplication. The earliest
are purely ad hoc models based on specific
datasets in the form ofequations derived
from regression analyses. These involve pre-
dicting a dependent measure, such as blood
lead concentration, when regressed against
an environmental measure such as soil or
dust lead concentrations. These statistically
defined models integrate measured data
into an inferential statement about the rela-
tionship oflead in some medium to some
measure ofbody lead burden, e.g., lead in
blood (PbB). We infer some overall rela-
tionship but cannot delineate the mecha-
nisms by which that relationship operates
physiologically, anatomically, or biochemi-
cally. Descriptively, these models are cross-
sectional in nature and assume that the
depiction of lead's behavior represents
steady-state conditions. An example ofan ad
hoc statistical model based on regression
data is that ofAngle et al. (3) linking child
PbB to urban environmental lead data.
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A relatively more sophisticated form of
(multiple) regression analysis, structural
equation modeling, represents a pathway
approach in which specifics of the path-
ways by which environmental lead sources
provide lead to human intake and uptake
can be ascertained to some extent. Here,
we can fill in some of the intermediate,
external steps between a lead source such as
airborne lead or lead paint and eventual
lead uptake.
The predictive value of statistical,
regression-based models is often limited to
the particular set ofconditions prevailing
in the study producing the model. The
more complex and widely applicable model
approach is the physiologic mechanistic
model, where one constructs as accurately
as feasible a quantitative, mathematical
simulation ofwhat happens when there is
lead intake and uptake. This simulation
assumes biokinetic mechanisms of lead
behavior in vivo. Historically, these models
have conceptually and computationally con-
sisted of the earlier classical compartment
models, the more recent physiologically
based pharmacokinetic (PBPK) model, and
hybrids ofthe two. The latter include the
U.S. EPA's integrated exposure uptake bio-
kinetic (IEUBK) model for childhood lead
exposure (4-7), the variable-age Leggett
model (8) and the O'Flaherty PBPK
model (9,10). These biokinetic mathemat-
ical models have focused on blood lead as
the predictive internal exposure marker.
The IEUBK model is a particular focus of
this paper.
Uses and Limits of Empirical
Data in Lead Exposure
Measurement
Empirical data refer to measurement
information gathered by experiment or
observation. Both forms ofempirical infor-
mation have commonly been gathered in
studies of human lead exposure. Exper-
imental approaches typically entail in vitro
or animal model studies ofspecific elements
ofexposure or exposure parameters not pos-
sible or appropriate in human studies.
Direct human experimental data in adult
volunteers and under institutional oversight
have been reported. Observational data are
numerous in the lead exposure literature
and have typically consisted of different
types ofepidemiologic assessments ofenvi-
ronmental lead exposures and exposures in
occupational settings. Observations, i.e.,
epidemiologic information, include both
measurements oflead in environmental
media and measurement ofbiologic markers
in exposed populations. Subsumed within
biologic monitoring are the various compo-
nents that are quantitatively significant in
contributing to an integrated expression of
exposure as determined by one example of
biologic monitoring, PbB.
Use ofempirical data in lead exposure
assessment can take several forms: measure-
ments in a research study, preliminary data
collection to establish more systematic
measurements, and lead exposure monitor-
ing frameworks through serial, systematic
measurements. These especially apply for
PbB data collection.
With reference to the utility and limits
ofempirical data in exposure model assess-
ment, the accuracy and validity ofempiri-
cal data used for calibrating or validating
the model is itselfimportant. A model for
estimating PbB values first requires we
validate or calibrate its output ofPbB esti-
mates bydetermining the relative reliability
or accuracy ofPbB sampling and measure-
ment methods employed for gathering PbB
data for direct comparison.
With regard to actual field measurements
ofhuman lead exposures, such data gather-
ing can be oftwo types: environmental mea-
surement and biologic measurement.
Environmental data can be obtained by lim-
ited measurements at one or few time points
or by monitoring levels oflead in environ-
mental media within some framework and
serially over time.
EnvironmenulLeadMeasurements
Environmental measurements of lead
represent potential exposures of popula-
tions rather than actual exposures ofsome
specific population. When such data are
combined with measurements ofsystemic
exposure, or dose, such as lead in some
physiologic medium like blood, one is able
to carry out inferential statistical analysis of
the relationships between the source and the
specific pathways oflead movement into the
body and eventually the bloodstream and
target organs. Although elevated lead levels
in environmental media encountered by
humans do not prove systemic exposure and
associated toxicity, the reverse situation is
equally problematic. Available biologic data
such as PbB screening results in the absence
ofenvironmental measurements severely
hinder quantitative conclusions aboutwhere
the lead is coming from and what lead
source or pathway one must remediate to
reduce or remove the exposure risk.
Environmental assessment necessarily
figures in the development and use oflead
exposure models. Statistical, ad hoc models
for sites such as those depicted in multiple
regression analyses require environmental
lead concentrations as the independent
variable in subsequent regression analyses.
Mechanistic physiologic, i.e., biokinetic,
models require environmental data for
input ofall the various lead intakes prior to
computational integration of the inputs.
This is just as true ofthe reported classical
compartment kinetic models as it is of the
PBPK models. Although certain biokinetic
models can make use ofdefault, best esti-
mate or generic concentrations for uniform
or centralized media sources such as diet or
drinking water, certain critical inputs such
as soil and dust lead are preferably derived
from site-specific measurements ifsuch val-
ues have been reliably determined. Reliable
and accurate site-specific data, preferable
for any predictive model that is still being
evaluated, should produce better concor-
dance between measured and predicted
results, compared to some defaultvalue.
Environmental measurement produces
results that are affected by a variety offac-
tors, e.g., the context or framework ofthe
data gathering, the sampling design for
media lead measurements, and the labora-
tory measurement methods. Environmental
lead assessments have been used in pro-
grammatic or systematic analyses over time
and space, i.e., site-specific monitoring over
some time period, and in the form ofsite-
specific measurements at some single point
in time. An example of the former is the
U.S. EPA's air monitoring network that
gathers multiple-site data for a variety of
purposes. A second example is groundwater
monitoring around or on a hazardous waste
site by monitoring wells. The latter moni-
toring is typically part ofthe resolution of
regulatory or litigatory action for Superfund
sites in which monitoring groundwater for
determining off-site migration is to be done
for manyyears.
Although air or groundwater lead
measurements may be done in some sys-
tematic monitoring framework, a number
ofother lead-containing media of interest
at some particular site are more commonly
examined on a single or limited repeat
sampling basis. This would typically be the
case for soil, dust, and paintsamples.
The environmental media sampling
design for subsequent lead measurements
can often be the largest source of uncer-
tainty and variability in arriving at most
exposure-representative statistical depictions
of environmental lead contamination.
These include the "what" and the "how" of
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media lead sampling. This is best illustrated
in the first instance by the question, What
does one collect for lead measurement in
the way ofenvironmental sampling? This
will be a difficult question to answer when
there is lack ofunderstanding or informa-
tion about what the sources and pathways
oflead are to the subjects under study. Lead
readily undergoes environmental cycling
into and out ofenvironmental compart-
ments that may also serve as exposure
mediaforhumans.
The complexity and interrelationships
among these compartments for lead are pre-
sented in Figure 1. This environmental lead
flow scheme permits one to determine some
ofthe environmental media that may need
to be analyzed for lead given some informa-
tion about the history ofthe locale vis-a-vis
sources oflead contamination. To illustrate,
soil lead contamination from a nearby sta-
tionary source such as a lead smelter means
that not only soil lead but also interior and
exterior dust, garden crops used as food, and
so forth should be measured. There may be
multiple lead source inputs to pathway
media such as soil and tapwater, e.g., air
lead fallout and leaded paint for soil, and
lead-soldered household plumbing joints
producing contamination oftapwater drunk
directly and contamination of any foods
cooked in the tapwater.
An equally vexing question in sampling
design has to do with how to sample a par-
ticular potential exposure locale. With dusts
and soils, does one use onlygrab samples or
gridded composites? What sampling proto-
col best captures any potential high hetero-
geneity of lead distribution in these site
media, e.g., soil contamination by lead
from multiple sources? With soils, there are
critical questions ofwhere to sample, what
should be composited, and what form of
compositing is most likely to reflect child
exposures. What depth ofsoil should be
examined? Soil plots used forfood crop gar-
dening should be sampled differently than
areas where children mainly contact the
uppermost centimeter or two ofsoil dur-
ing extended play. Various reports have
appeared addressing these issues in a regula-
tory context and they include but are not
limited to the U.S. EPA's 1989 Risk
Assessment Guidancefor Superfund (11).
This source includes guidance on how to
deal with various sampling design issues for
environmental contaminants in human
health risk assessment.
Sampling protocols should also reflect
the physical and physicochemical character-
istics ofthe media that are most relevant to
Figure 1. Flow schemefor lead inthe environmentalong pathways to human exposure. Modifiedfrom U.S. EPA(25).
intake and subsequent internal exposure by
such riskgroups as infants and toddlers. For
example, soil samples ofdiverse particle sizes
should be tested for lead only after those
partide sizes within soil samples that reflect
likelyhuman intakes ofsoil lead are first iso-
lated andanalyzed. The smaller size soil par-
ticles, i.e., those < 150pm, are those most
likely to be ingested, most likely to be trans-
formed in terms oflead release, most likely
to have the highest relative lead content, and
the fraction(s) most likely to be associated
with biomarkers ofexposure and ofadverse
effect (12-14).
Sampling protocols ideally should
include measurements that may say some-
thing about the source of lead in that
medium. For example, proximity ofsoils to
a curb versus soils at a house roofdrip line
may reveal lead concentration patterns that
reflect input sources. High lead levels at
medians between sidewalkand roadway but
lower lead levels farther from the road
suggest auto exhaust lead from pastgasoline
lead use. High lead concentrations in a soil
band corresponding to the drip line suggest
paint lead orwashing offofdeposited parti-
cles from air lead fallout. A declining soil
lead gradient with increasing distance from
exterior building surfaces suggests lead
paint. Similarly, tapwater lead that varies
markedly with flushing would implicate
unit plumbing, e.g., lead-soldered copper
plumbing fittings, rather than an elevated
water lead concentration entering the unit
from outside (15).
In the case ofdust sampling, there are
the questions ofwhere to sample and how
much to sample, particularly in contact
areas for children. These questions should
be linked to what one knows about the
interactions of exposed individuals with
soil and dust-contaminated areas. Iflarge
quantities of household dust are to be
collected, sampling in residences where
general housekeeping practices prevent
accumulating dust on surfaces in chil-
dren's play areas may force collections in
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historical dust accumulation areas such as
under furniture, and in unused rooms,
attics, basements. These areas might show
less association with ongoing child lead
exposures than areas ofchild activity.
Although laboratory methods that pass
quality assurance and quality control proto-
cols are generally available for lead in a
number ofmedia, laboratory methodologi-
cal issues remain for dusts and soils (16).
Laboratory methods for lead analysis are
now relatively standardized and prescriptive
in the contract laboratory program of the
U.S. EPA for those sites that figure or
may figure in regulatory or litigatory
actions. A further issue is how to quanti-
tate the lead contamination in samples
collected inside residences, especially dust
samples. Traditionally, one measured the
concentration oflead in soils and dusts per
unit mass, typically as parts per million.
Milar and Mushak (17) first used lead
measurements based on concentrations of
lead per unit surface area as well as the con-
ventional expression in mass concentration.
Lead content per unit area for quantitation
helps to better define the parameter ofdust
loading rates and the highly variable para-
meter ofhousehold cleaning practices (17).
The quantification by unit area approach in
subsequent investigations has been shown to
be a better reflection oflikely human lead
exposure than the concentration-per-unit
mass method (18).
Measurable Biomarkers of
Human LeadExposure
The NRC (19,20) defines a biologic
marker of exposure as an exogenous sub-
stance or its metabolite (in some testable
biological medium) or the product of an
interaction between some xenobiotic agent
and some target molecule or cell. There are
also biomarkers oflead effect and of lead
susceptibility, but these are outside the
interests ofthis paper.
Figure 2 depicts two types oflead expo-
sure biomarkers: physiologic fluids such as
whole blood (PbB) or plasma lead (PbP),
and mineral tissue markers (lead in bone
[PbBone] and teeth [PbT]). PbB has been
and remains the most popular biomarker. It
is also the one that is both readily under-
stood as to methodology and for which gen-
erally accepted dose-response relationships
exist in terms ofPbB thresholds associated
with adverse effects. This dose-response
relationship is depicted in Figure 3 as an
analogy to a thermometer, as depicted by
Mushak (21) and as adapted from the
Agency for Toxic Substances and Disease
Figure 2. Characteristics of lead exposure biomarkers.
Registry (ATSDR) (22). The amount of
body lead burden determines the reading in
the form of the number ofeffects whose
thresholds have been crossed. Analogous
depictions have been reported (23). Figure
3 shows thresholds in PbB for the full spec-
trum ofadverse health effects in infants and
toddlers. At a PbB of 10 1ig/dl, a battery of
effects discernible on a group basis and
involving the developing nervous system
begins to be apparent. At the other end of
the PbB range, 100 ig/dl and higher, con-
vulsions, coma, and death become increas-
ingly likely. PbB represents mainly recent
lead intake and uptake in infants and tod-
dlers having modest lead exposures, with an
associated biologic half-life range on the
order of 3 to 6 weeks (1,24-28). With
increasing age and/or body lead burden, the
fraction ofbody lead accumulated in bones
begins to increasingly contribute to the total
quantity ofPbB through resorption.
Two human exposure categories that
represent the extremes of current versus
cumulative lead inputs to blood can be
identified. The infant and toddler with low
exposure would have PbB reflecting almost
all recent lead intake, whereas retired adult
lead workers with a long working history of
heavy lead exposure would show practically
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Figure 3. Full spectrum lead dose response. Modified
from ATSDR (22).
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all PbB arising from PbBone lead resorption
after leaving the workplace exposure.
Adults with mainly moderate environmen-
tal lead exposures will have PbB concentra-
tions arising from variable inputs from
both current intakes-and historical PbBone
releases, the latter being further increased
during pregnancy, lactation, and post-
menopausal periods (1,24). The labile
nature of PbB in infants and toddlers in
absolute terms makes it difficult to recon-
struct earlier exposures without the avail-
ability of, e.g., serial PbB data collected
over a reasonable time.
Infants and toddlers with relatively high
lead exposures, as might occur in deterio-
rated housing in inner-city neighborhoods
in America's largest cities, have been shown
in some studies to have a higher fraction of
total PbB from some slower kinetic compo-
nent than that which reflects recent absorp-
tion and that probably includes PbBone,
even though the PbBone turnover rate is
assumed to be quite high in this age group.
Succop et al. (29) employed statistical
analysis ofserial blood data to calculate a
half-life of 10 months in PbB ofinner-city
Cincinnati children. Angle et al. (30) noted
that analysis ofstable lead isotope ratios in
inner-city Omaha toddlers indicated that a
measureable, significant part ofPbB arose
from endogenous sources rather than recent
intake sources. These reports have obvious
implications for lead remediation strategies
where PbB reduction is the biologic index
ofreduced exposure. That is, the total PbB
decline that would be associated with reme-
diation will require a period oftime to be
realized if the starting body lead burden
lodged in bone before remediation is
relativelyhigh.
A second toxicokinetic issue for human
exposures is the nature of the PbB rela-
tionship to lead in environmental media.
It is generally observed (25) that over a
large range of environmental lead levels,
the corresponding group PbB is curvilin-
ear downward at the higher end ofthe lead
intake range. Experimental data suggest
one factor that may be operating is the
dependence of lead uptake on the lead
concentration in ingested or inhaled media
(31,32). Chamberlain (33), however, also
invokes an exposure-dependent increase in
urinary excretion, based on his studies of
workers with occupational lead exposures.
Flanagan and co-workers (34) reported
that human adult volunteers acutely
ingesting lead as a single dose over a range
of4 to 400 pg/day had the same uptake
rate, but it is unclear whether chronic
intakes over this range would actually
show dose dependency of uptake after
achieving a stable PbB value.
Although overall PbB may show a
declining slope relationship at high intakes,
the overall direction ofPbB is still upward.
The fractional distribution oftotal PbB to
plasma increases with a PbB increase above
50 to 60 pg/dl (35,36). Because this is the
point along the PbB versus lead intake
curve where change in slope also occurs, the
nature ofthe curve at high intakes may be
reflecting more efficient removal ofcircu-
lating lead through plasma. This would
indicate that tissues continue to receive a
relatively linear lead load through plasma.
This, in fact, appears to occur. Relative lin-
earity in tissue lead increase with intake is
seen when one compares dosing lead levels
with selected tissue lead levels for rodents
(37) or dogs (38). Increased urinary lead
output may occur as well with increasing
intake, but its magnitude is not enough to
void the linearity of the tissue lead-lead
intake relationship, or the upward curvilin-
earity of the PbP versus increasing lead
intake relationship.
The relative accuracy ofPbB measure-
ments on an individual or population
group basis is determined by a host offac-
tors. It is imperative to comprehend the
impact ofthese factors on PbB data before
one can use such information to draw con-
clusions about the extent oflead exposure
in a community or to evaluate (validate
and calibrgte) lead exposure prediction
models. These factors include a) the
nature of the PbB gathering process with
respect to existence or absence ofany pro-
grammatic infrastructure, b) the biokinetic
nature ofthe PbB measurement itselfand
how it's affected by the type ofPbB survey;
and c) the quality ofthe epidemiologic and
biostatistical design employed for carrying
out the PbB surveyprogram.
A critical factor in blood lead measure-
ments is the nature ofthe PbB data gather-
ing. PbB screening within a programmatic
public health framework and including ser-
ial testing, i.e., PbB monitoring, has a num-
berofadvantages over a "single-shot" testing
effort specifically looking at a particular
community's lead exposure sources. With
the latter, there can be considerable uncer-
tainty orvariability, with little possibility of
easy resolution since there is typically no
follow-up or monitoring framework. The
typical structured PbB data gatherings in
screening programs are those managed by
various states, counties, and cities with
added input and support from the Centers
for Disease Control and Prevention. These
programmatic surveys assure that high-risk
lead exposure children will be multiply sam-
pled over their high-risk age band with a
follow-up structure for assessing effects of
leadsource remediation, wheresuch is done.
A second structured PbB data gathering
example is the nationwide surveyofthe U.S.
population's PbB mean and distribution for
a given time period, statistical "snapshots"
ofnational lead exposure in the National
Health and Nutrition Examination Surveys
(NHANES) conducted by the U.S. Public
Health Service. These surveys, e.g., the sec-
ond and third NHANES [NHANES II
(39) and NHANES III (40)], are statisti-
cally designed so that they employ an
intensive canvassing effort of socioeco-
nomic and demographic strata within a
cluster-sampling, aggregated model that also
involves extremely rigid, standardized study
designs and rigorous quality assurance/qual-
ity control protocols for assuring accurate
biologic measurements, induding PbB mea-
surements. A single large team carries out
NHANES studies. The NHANES-type sur-
vey is a single-sampling effort for all the
stratified communities, selected for position
in a statistical design serving a global nutri-
tion and health assessment, not for having a
lead problem. NHANES surveys, although
done once in a statistical community, bear
no interpretive similarity to those single sur-
veys that have as their purpose assessing a
specific community's potential lead problem
onlyonce.
Single PbB surveys, as maybe employed
in a single community at a single point in
time and with little programmatic frame-
work for follow-up, potentially can be lim-
ited by a variety of methodological and
interpretive problems, especially iflinks to
sources oflead exposure that produce PbB
elevations are sought. Examples ofstudies
oflead-exposed communities in terms of
PbB and environmental lead measures are
known (41-43).
One difficulty with single-shot PbB
assessments that are focused on lead expo-
sure per se is that the relatively rapid
response of PbB in the very young to
abrupt changes in lead intake may affect
the single-effort results. A specific problem
is the extent to which public awareness of,
or focused education efforts on, a publi-
cized lead problem in a community alters
caregiver behavior so as to abruptly restrict
child activity and associated lead exposure.
This produces a biokinetic and epidemio-
logic artifact by lowering PbB at the time
of sampling. Such reduction would be
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most welcome ifpermanent, but would
likely only be transitory without a perma-
nent framework for continuing awareness
and education. Lead exposure would even-
tually revert to its previous level.
The relationship ofcaregiver awareness
to abrupt changes in PbB appears in the
recent, preliminary PbB results ofGoldman
and co-workers (44,45) for the Children's
Lead Exposure and Reduction Study
(CLEARS) in Jersey City, New Jersey.
Children ofparents whose overall awareness
and response to systematic education about
lead hazards were higher at testing than that
of other parents had a mean PbB four
points lower than children ofless aware par-
ents. This difference occurred with mean
PbB levels in the group that represented sig-
nificant elevations. The CLEARS data for a
robust intervention suggest a significant
average decline (about 4 pg/dl). Such
absolute level declines occur whether or not
relative linkages in terms ofrank order per-
sist. Mushak (1), Dietrich et al. (46), and
Otto et al. (47) noted findings that groups
ofchildren evaluated at some earlier time in
terms ofPbB level can preserve the relative
ranking of the PbB value in later testing.
The basis ofthese observations theoretically
can arise from the relative size ofendoge-
nous lead release to blood, persistence of
proportional external lead contact, or a mix-
ture ofboth. Abrupt shifts downward in the
number or fraction ofchildren above some
not-to-exceed risk or toxicity threshold level
would arise from groupwide abrupt declines
in PbB with restrictions in exposures.
Preservation of rank order says nothing
about the absolute PbB values in any later
testing setofoutcomes.
Finally, there is the problem ofappro-
priate study design for these ad hoc, single
surveys oflead-exposed communities. A
number ofsuch recent surveys done for a
single community were done using study
designs that pose considerable uncertainty
as to identification of the most highly
exposed risk population segments and the
relationship ofthat study group's exposure
to particular sources and pathways oflead
exposure, e.g., exposures to extractive
industry wastes. Little standardization of
study designs in these lead-exposed com-
munities has been done. Different
researchers studying the same community
can arrive at quite different results,
depending on the nature of the study
design. A good example ofthis disparity of
interpretation is a single PbB survey carried
out in an Illinois Superfund site commu-
nity by contractors for Illinois and the U.S.
ATSDR (48). The contractors concluded
there was no impact ofthe site, a defunct
smelter, on children's PbB concentrations.
A more detailed U.S. EPA analysis, using
structural equation modeling, did show a
clear relationship (49). In some ofthe older
single-shot studies oflead exposure, partic-
ularly those reported in the 1970s or earlier,
the qualityofthe studydesign and methods
employed were highly questionable and
resulting data should be considered
suspect (12).
The overall problems with assessment of
reported single-shot surveys over the years
for lead-exposed communities extend to
reviews ofsuch data. The review of Danse
et al. (50) concluded that lead in mill tail-
ings at many thousands ofparts per million
in and around extractive-industry commu-
nities do not pose any lead exposure threats
to children living there. This conclusion
was based on an evaluation ofhistorical
data that was based on superficial assess-
ments of these data, including neglect of
the many nuances and complexities ofthese
datasets. A number ofthe same studies and
study sites were also evaluated in a 1991
critical review by Mushak (12), and the
interested reader should consult this paper.
In particular, the communities referred to
by Danse et al. produced a large amount of
problematic PbB data. In other cases,
Danse et al. misinterpreted the more reli-
able information. For example, the 1981
Australian study ofHeyworth et al. (51)
actually shows, when the original data are
analyzed, a clear link between mill tailings
in the play environment ofchildren and
elevations in their PbB. In other cases, com-
munities reported byMushak (12) as show-
ing a relationship between mining and
related waste and PbB were not mentioned
by Danse et al. The discussion by Danse
did not stratify the available data for PbB
versus extractive-waste sources as to relative
reliability ofstudy designs, lead measure-
ment methodology, representativeness of
the community characteristics. and appro-
priate presentation of data, e.g., use of
mean values instead ofdistribution ofPbBs
above toxic threshold levels. Rather, Danse
et al. used indiscriminate mixing, tabula-
tion and interpretation ofPbB values for
mill tailing communities. PbB data from
small group samplings in the 1970s were
combinedwith more recentsurveydata.
In summary, single PbB surveys carried
out in lead-impacted comm4nities where no
follow-up is planned need to be carefully
scrutinized as to theiraccuracyandreliability.
Potential problems with any effects of
publicity or awareness on transitory drops in
PbB levels should be examined, as should
the appropriateness of the study design
employed. At this time, we can say that
available information in the literature exists
to carry out more reliable PbB studies, espe-
cially with reference to study design issues.
Where environmental data are gathered in
tandem with such PbB data gathering, sam-
pling and measurement methods also need
to be carefully scrutinized. PbB surveys that
a) involve a valid statistical design, b) show
no impact ofawareness or publicity on tran-
sitory reduction ofPbB levels, c) permit fol-
low-up with future PbB surveys ifnecessary,
and d) are coupled with environmental
measurements that are accurate, precise, and
statistically representative oflikely actual
contact by risk groups such as infants and
toddlers, would be more reliable and ofbet-
ter utility to the validation and calibration
ofpredictive lead exposure models where
PbB estimates are produced.
An exposure biomarker related to PbB
is PbP. Biologically, plasma is the medium
bywhich lead is borne from the blood com-
partment to target tissues and organelles.
Consequently, we might expect that the
more precise dose-response relationships
for lead and human adverse health effects
would arise from linkage ofeffect outcomes
to PbP concentrations. However, the many
methodological problems that plague use of
this measure dampen its utility in lead epi-
demiology and dinical toxicology. Within a
range of PbB up to about 50 pg/dl, the
equilibrium relationship of PbP to PbB is
relatively stable as a fixed percentage of
PbB. At higher PbB concentrations, the
fraction ofPbP begins to increase and the
plasma-whole blood relationship becomes
curvilinear upward with increasing PbB lev-
els. This may be a factor in loss of PbB's
linear relationship at higher environmental
lead intakes as overall tissue lead is more
linear than PbB. It should be noted that we
are not speaking here ofvery transitory
shifts in PbP that occur with uptake oflead
after, for example, eating a meal or drinking
water. The longer term equilibrium holds.
Methodological problems in the mea-
surement and use of PbP are severe.
Concentrations ofPbP are at extremely low
levels relative to PbB. The fraction oftotal
PbB that is not in the erythrocyte is only
about 1% (25,52). In the case ofa PbB of
10 pg/dl, the corresponding PbP would be
about 1 ppb in blood and about 2 ppb in
separated plasma. The very low fractional
distribution into plasma also means that in
the presence ofeven slight hemolysis, PbP
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becomes markedly contaminated with
erythrocyte lead. A particularly vexing
problem is that as PbB increases with
increasing lead exposure, erythrocyte
fragility and osmotic resistance are greatly
enhanced, so that hemolysis is even more
likely at elevated PbB concentrations where
precise dose-response relationships would
be ofparticular interest. Additionally, the
hazard of contamination with nonbio-
logic, environmental lead in the sampling
or laboratory environment is quite high at
the low levels that are typically present.
Contamination of 1 ml ofplasma with
2 ng ofleadwould double the PbP concen-
tration expected at a PbB of 101gIdl. The
final problem with PbP is interpretive and
diagnostic in nature. We have little idea at
this point what a particular PbP means in
terms of toxicity risk or manifestation in
an individual with an elevated level.
Consequently, the accepted and readily
comprehended dose-response relationships
across a wide toxicity spectrum using PbB
concentration as the dose measure are not
paralleled using PbP concentration as the
dose measure.
Lead in mineral tissue, unlike PbB or
PbP, serves as a biomarker of cumulative
lead exposure. Mineral tissue exposure
biomarkers are oftwo types anatomically,
physiologically, and biokinetically. These
are PbT and PbBone. PbT is the better
known biomarker ofcumulative exposure.
Lead deposition in tooth tissue begins
with calcification ofenamel before erup-
tion. Secondary dentine lead reflects lead
accumulation from mainly the time of
eruption to shedding. PbBone is cumula-
tive from childhood through about the
sixth decade of life. PbT is much less
kinetically mobile than PbBone in young
children in that release from the several
compartments ofbone back to blood can
readily occur in children.
The uses and limits of PbT data for
lead exposure vary greatly from that
involving PbB. The levels ofPbT, particu-
larly in the highly lead-enriched circum-
pulpal dentine region, reflect lead exposure
generally integrated over the early life of
the child. This integral of exposure
encompasses infancy and toddler life,
where lead exposure can be higher and the
developing child is most vulnerable to sys-
temic toxicity effects. Accumulation con-
tinues through older childhood, when
teeth are shed.
Although efforts have been made to
model the quantitative relationship ofPbT
to PbB, thereby providing more predictive
flexibility to PbT as a dose measure
(53,54), the state ofthis research is largely
incomplete. It may not be easy to accurately
predict a temporally averaged PbB during
the high vulnerability years from a single
PbT value. Accumulation of lead by
episodic or pulsed high exposures as in
acute paint chip or flake ingestion or by
chronic, low-level lead intakes from multi-
ple sources may have different implications
for toxic responses. Regardless ofthe his-
tory ofaccumulation, many studies show
significant associations between PbT and
some neurotoxic outcome measure (24).
Although PbBone is also a lead accu-
mulating marker with potential use in
assessing long-term subject exposure, this
marker is only now being explored as a bio-
marker ofenvironmental lead exposure in
children (55,56). This measure typically
involves X-ray fluorescence (XRF) via in
vivo measurements using either K or L X-
rays. The different X-ray approaches appear
to probedifferent portions ofthe bonecom-
partments for lead. Bone XRF for lead has
been in the research stage methodologically
and interpretively with reference to general
population lead exposures, but is being
applied to some groups with exposure histo-
ries in childhood. Farther along is use of
XRF spectrometry in assessing long-term
occupational lead exposure (24,28,57-59).
These applications ofthe method typically
involve cortical or trabecular PbBone mea-
surement, are carried out with a history of
serial PbB measurements, and with an
employment history in lead worksites. As
noted in the next section, these different
measures areintercorrelated.
Recent XRF studies of lead workers
describe the very close correlation between
serial PbB data in cumulative form (mean
annual PbB x work-years) and tibial (cor-
tical) or heel (trabecular) PbBone concen-
trations measured by K-line XRF analysis
(57-59). Because both measures are bio-
chemically linked ways to define cumula-
tive body lead burdens, we would expect a
high correlation. In typical environmental
exposure settings involving children who
are not taken to be in high-risk popula-
tions and therefore not included in pro-
grammatic screening, serial PbB data are
rarely available. A critical interpretation
question for PbBone levels by XRF analy-
sis is what a lead measurement means in
terms oftoxicity risk or clinical manage-
ment ofexposed subjects. Does a cortical
PbBone level ofX ppm indicate sufficient
lead exposure has occurred or is occurring
to produce lead poisoning? Which ofthe
various bone measures most closely relate
to what potential adverse effect?
The relative utility ofPbT and PbBone
data to risk managers or regulatory policy
makers concerned with real-time lead con-
trol challenges is obviously more limited
than would be PbB data for the same pop-
ulation. Newly gathered PbB data in terms
of means and statistical distributions can
dictate the need for prompt remediation
and some expectation that such interven-
tion will produce a lowering oflead expo-
sure and reduced poisoning risk. Elevated
lead levels in teeth or bones of children
indicate exposures that have already
occurred, including but not limited to the
more distant past. Exposures measured this
way mayhave already produced toxicologic
effects and lead remediation actions might
not be taken soon enough to benefit these
particular children. However, results ofele-
vated lead levels in bone and teeth ofchil-
dren from contaminated settings in which
there are still children beingexposed would
be of benefit for prompt intervention
directed at protecting currently exposed
infants and toddlers.
Uses and Limits of Empirical
Data in Lead Exposure Model
Evaluation
Predictive statistical or biokinetic models
oflead exposure, like all model simulations
ofbiologic phenomena, require evaluation
for general validity and case-specific or
application-specific accuracy. However,
before empirical data can be employed in
any quantitativeway for assessing a model's
value, there are several overarching ques-
tions about model evaluation (validation
and calibration) that help guide use ofsuch
empirical data.
HowGod IsGoodEnough?
One basic question is how predictively
accurate a model oflead exposure or any
other model simulating biologic behavior
has to be to be acceptable for some applica-
tion. Such a question is logically subsumed
under an allied one: What is the purpose to
which the model is being put?
Ifthe model user seeks predictive esti-
mates within a rather broad range and/
or is using predictive data as but one ele-
ment in a large cluster ofcriteria for risk
management of a site, such as decisions
about aSuperfund site, the required level of
agreement between empirical data and
model outputs may not beveryhigh. Ifpre-
dictive data are being sought with reference
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to some finite threshold value in permissible
lead exposure or some cutoff level in lead
exposure distributions, then model perfor-
mance maybe more rigorously evaluated. A
key issue, therefore, is the required level of
prediction performance for some particular
application. For example, is the U.S. EPA's
IEUBK model reliable for evaluating child
lead exposures at Superfund sites?
A related qualifier is the extent to which
some particular model for some site- or
scenario-specific use is flexible for multiple
uses by the regulator or risk manager. For
example, biokinetic models such as the U.S.
EPA's IEUBK model for children (4-7) or
the O'Flaherty PBPK model for children
and adults (9,10) theoretically permit
assessment of the results ofaltered land
uses, altered population demographics, or
impact oflead remedial actions in future
years on body lead burdens indexed by
PbB. Such applications should not require
recalibration with empirical data for every
such use, ifa baseline calibration has been
done. One can also use these models for
reconstructing lead exposures at remote
time points. Mushak (27) used the U.S.
EPA's IEUBKmodel to estimate the typical
mean PbB ofpreindustrial children, based
on archaeological and uncontaminated
environmental leaddata.
UsesandLimitsofEmpimcal Daain
U.S. EPAs IEUBKModdEvaluation
The balance of this article deals with the
uses and limits ofempirical data in the
evaluation of biokinetic models of lead
exposure, particularly the U.S. EPA's bio-
kinetic model for childhood lead exposure.
Certain parameters are ofspecial interest
with reference to the U.S. EPA's biokinetic
model. First, there is the form ofthe pre-
dicted exposure output, i.e., the predicted
or estimated geometric mean PbB, gener-
ated distributions of PbB, and associated
descriptive and inferential statistics. One
therefore is first concerned with how reli-
able the model's PbB predictive estimates
are, what factors affect this output, and
what factors may explain differences
between the modeling results and empirical
PbB data used for comparative evaluation.
Use ofthese factors and their limits for
validating and calibrating lead exposure
model predictions comprise a significant
section of this article. They constitute a
rapidly evolving area ofresearch, an area of
research that has only been sketchily evalu-
ated so far and therefore is still poorly
understood by many in the lead research
community. Therefore, evaluation ofthese
developments must be done at a higher
level ofdetail than given to earlier topics
and sections in this article. This includes
the various facets oflead bioavailability.
One must first establish that PbB
datasets from surveys to be used for evalu-
ation ofthe IEUBK model are themselves
reasonably reliable, and some of the
means or criteria for doing this were pre-
sented earlier. One should also view eval-
uation of this or any other model with
reference to some intended application.
This is consistent with the administrative
and regulatory history of the IEUBK
model's scientific review by, among oth-
ers, the Science Advisory Board (60,61).
So far, the model has been technically
approved for use in risk assessments associ-
ated with stationary lead emission sources
(60) and Superfund waste site lead in
potentially exposed communities (61).
Generally, biokinetic model evaluation
consists of both a validation step and a
calibration stage. The former refers to
establishing the overall computational
soundness and the plausibility of the
biological simulations in the model. The
latter addresses adjustments or fine-tuning
of a generally valid and applicable model
using reference data, typically from on-site
measurements. The general assessment of
the IEUBK model has been carried out by
U.S. EPA's Technical Review Workshop
for Lead (6) and model evaluation includes
documentation of the model's scientific
basis, code verification, and representative
empirical comparisons.
Efforts have been made to compare
the predictive accuracy of the IEUBK
model at extractive industry sites with
single, unstructured PbB surveys (see
above). These PbB surveys are themselves
potentially problematic, and must be rea-
sonably shown to be reliable before they
can serve as a means to calibrate or other-
wise assess modeling data. What should
be the level of calibration? Any model
that must always be fine tuned with a sin-
gle set of current conditions ascribes
intrinsically little value to the reliability of
that model across the whole spectrum of
its likely uses. A major use of the U.S.
EPA IEUBK model for risk assessors and
risk managers is prediction of PbB data
when detailed site characterizations by
other means are not possible and when
there is need to simulate future or alterna-
tive exposure risk scenarios with changes
in environmental lead concentrations or
affected populations. These include
future changes in contaminated land uses
and demographic or socioeconomic changes
in the affected populations.
Evaluation ofBiokinetic
Modd InputParameters
Any disagreement between biokinetically
predicted PbB results and accurate PbB
measurements indicates that there are
discordances in input parameters (assum-
ing basic computational soundness). The
U.S. EPA IEUBK model contains a num-
ber of input steps where uncertainty and
variability can arise. Two are ofsignificant
importance and are discussed in detail.
They are a) the bioavailability or uptake
rate oflead from media directly relevant to
infants, toddlers and older children, and b)
the amount oflead-contaminated medium
that is ingested.
BioavaiiabilityofLeadin
Human IntkeMedia
Bioavailability of lead in a toxicologic
context is defined as the rate and extent of
lead absorption or uptake to the central
body compartment (bloodstream) from
receiving body compartments ofthe lung
and gut via the exposure pathways of
inhalation and ingestion (12,62). Because
childhood lead exposure is the focus ofthe
IEUBK model, bioavailability oflead from
the gastrointestinal tract in this highest-risk
age band is ofparticular interest.
There are a number ofgeneral host and
external factors that govern lead bioavail-
ability in human populations, and espe-
cially preschool children (1,4,5,12,16,
24-27).
Infants and older children absorb lead
at a higher rate than do adults in terms of
lead uptake rate and in terms ofintake and
uptake per unit body measure, e.g., body
mass or body surface area. In addition,
preschoolers, especially older infants and
toddlers, readily explore their environment
orally, i.e., they ingest lead-contaminated
materials via hand contamination and
mouthing their fingers and/or direct inges-
tion ofdusts, soils, or other contaminated
materials. An extreme form of this behav-
ior is pica, and pica for soil is called
geophagia. These behavioral and develop-
mental physiologic characteristics have
been the subject ofvarious studies over the
last several decades.
Studies with human infants show that
lead uptake from infant diets is on the
order of 50% (63,64). A small group of
mixed-age children studied byAlexander et
al. (65) indicate that similar lead uptake
rates maypersist to lateryears, but the small
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sample size and the wide age spread (to 8
years of age) makes this figure tenuous for
older children. Human adults typically
absorb lead from ordinary diets in the
amount of 10 to 15% of the dietary lead
intake. With fasting conditions, adults can
show higher uptake rates, paralleling those
of infants at -50% or higher. This demon-
strates that intrinsic gut changes can be less
a factor than presence or absence ofdietary
factors and their interaction with lead, e.g.,
the lead-calcium interaction (66-69).
Experimental animal studies generally
support a much higher uptake of lead in
the very young child compared to adults,
and these studies are critical to the develop-
ment and use of animal models of lead
bioavailability for infants and toddlers.
Studies with nursing rodents indicate that
uptake rates are quite high compared to
adults or juveniles (70-72). At weaning,
however, lead uptake and retention rates
abruptly and steeply decline to those ofthe
adult. The infant monkey (73) absorbs
much more lead, about 50%, than does the
juvenile or adult monkey (74). Kierski
(75) showed that the weanling rabbit, 5
weeks old, absorbs twice as much lead from
ingested soil as does the older rabbit. The
juvenile swine, interestingly, may be farther
along developmentally than the human
infant but still appears to absorb lead at rel-
atively high rates from dosed animal feeds
or diet augmented with various leaded soils
(76-82).
Persistence of the elevated lead uptake
rate through early childhood is still the
subject of some uncertainty. Infants up to
24 months old absorb lead at about 50%
of intake. There is little conclusive evi-
dence that human infants aging to toddlers
of2 to 4 years undergo specific gut changes
that would result in significantly lower
uptake of lead in the toddler stage. Diet-
related changes, rather than alterations in
gut uptake, may play a role in altering
uptake, however. Infants have high meta-
bolic requirements for essential elements
but so do toddlers, owing to explosive
growth requirements and the attending
need to offset known common deficiencies
in essential elements such as calcium and
iron during the toddler years. It is well
known that deficiencies in iron and cal-
cium enhance lead uptake (24,69,83,84).
O'Flaherty (10) assumed for PBPK model-
ing purposes that the 5-year-old child has a
lead uptake rate from diet of half that of
younger children (25%).
Epidemiologic data on age versus PbB
relationships in children in different lead
exposure settings are consistent with persis-
tence of a relatively high lead absorption
rate in the gut from late infancy (24
months) to 3 years ofage (36-47 months),
and a discernible lower uptake rate at 4 and
5 years of age. The longitudinal study of
low-level lead effects in children in the lead
smelter community of Port Pirie, Australia,
by Tong et al. (85) supports this statement.
This paper tabulated geometric mean (GM)
PbB values for the child cohort from prena-
tal to the 11- to 13-year age band. Such data
indicate that the GM PbB at the end of
infancy (24 months) when oral exploration,
mouthing activity, and ingestion ofdust and
soil is ongoing, and the GM at 3 years of
age when such mouthing activity is still
largely continuing but tapering offsome-
what, differ by only about 10%. Such mod-
est change, attributable in part to some
decline in mouthing activity, suggests that
the 3-year-old (36-47 months ofage) in the
Port Pirie study was absorbing lead at about
the same rate as the late infant. Data from
Tong et al. also show that the 4- and 5-year-
olds have a PbB GM about 30% less than
the 24-month-old infants. A significant part
of this decline is arguably the cessation of
mouthing activity and it is likely that the
reduction cleanly attributable to reduced
uptake rate between these age bands is com-
paratively much less than 30%. The
O'Flaherty assumption (10) of a 50% rela-
tive decline in uptake rate from infancy to
the 5-year-old age band, 50 to 25%, may be
an underestimate of persisting uptake rate.
As the Australian study used a large number
ofcohort subjects (n=368-372), a careful,
longitudinal study design, and a stable, mul-
tidisciplinary research program, their results
merit serious attention.
Mahaffey et al. (86) reported preliminary
data suggesting that lead uptake rate in 6-
year-old children approaches the adult value.
These findings are based on only a few sub-
jects, however, and require further research.
In overview, ifwe assume that attenuation of
lead uptake in the child's gut is underway
after about 4 years of age, and reduced
uptake is quite discernible in 6-year-old chil-
dren, then the older child of7 and 8 years of
age probably resembles the adult with regard
to any intrinsic versus dietary differences in
lead absorption via the gut.
Approaches to Childhood Lead
Bioavailabilityfrom Other Media
Although lead uptake rates from diet and
water in the preschool child are assumed to
be greater than for the adult under the con-
ditions indicated above, there is growing
interest in the extent of lead uptake, i.e.,
bioavailability, from other media, such as
those generated through various industrial
or waste disposal practices. This is especially
so where such media exposures occur as part
ofvarious litigatory and regulatory actions
dictated by Superfund and related statutory
requirements. Uptake of lead from such
media also are at issue in modeling lead
exposure at sites, especially modeling with
the U.S. EPA IEUBK model.
Bioavailability of lead in various media
can be quantified in two ways, as absolute
bioavailability or relative bioavailability.
Absolute bioavailability is typically deter-
mined as the percent or fractional uptake
of lead from some ingested medium rela-
tive to an injected dose, both being quanti-
tated typically by area-under-the-curve
(AUC) techniques (62). The injected dose
is assumed to represent 100% uptake.
Relative bioavailability is taken as the ratio
oflead uptake from some ingested medium
relative to a reference ingested dose of a
soluble lead salt, typically the acetate, unaf-
fected by containment in some formulary
or geochemical matrix (12,62). Relative
bioavailability is only useful if this parame-
ter, determined in an animal species, is
quantitatively comparable with young chil-
dren ingesting lead from such media as
soil, compared to children ingesting solu-
ble lead from tapwater or diet. The experi-
mental surrogate for diet and water lead is
typically lead acetate.
There are various approaches by which
one can empirically evaluate lead bioavail-
ability as an input parameter to biokinetic
models, including the U.S. EPA IEUBK
model. The integrated expression of
bioavailability in tandem with other para-
meters is the measured PbB level, assuming
this parameter is without serious error and
problematic interpretation. Various factors
contribute to PbB variability. These include
the amount of material ingested, behavioral
interactions of the child and the environ-
ment, and lead sources beyond those being
evaluated. A specific, uncluttered assessment
ofbioavailability is therefore often preferred.
Because studies in children are highly
restricted, the options are data from animal
models ofbioavailability under controlled
dosing conditions or in vitro simulations of
in vivo bioavailability using benchtop,
nonbiological procedures.
ExperimentalAnimal Models ofLead
Bioavailability in the Preschool Child
Several animal test systems oflead bioavail-
ability have been recently described,
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differing in the choice of test animal
species, the lead-containing matrix, and
dosingprotocols. Byandlarge, bioavailability
oflead from the diverse media administered
to animal models ofchild lead bioavailabil-
ity was quantified in terms ofPbB concen-
trations, rather than lead in other body
compartments. Blood is the vehicle (via
PbP) by which the toxic dose of lead is
delivered to target organs oflead in the fetus
of pregnant women and particularly the
brain ofthe developing infant and toddler.
This measure also more temporally tracks
recent or ongoing uptake, and bioavailabil-
ity is commonly understood to be a more-
or-less real time process. Equally important,
PbB has been established as the dose part of
the many dose-response relationships for
the various toxic effects oflead. Other accu-
mulating tissue lead burdens, e.g., PbBone,
are not readily linked to, or universally
accepted for, dose-response relationships in
exposed human populations. Several investi-
gators have measured lead in animal body
media other than blood (87).
Choice ofExperimentalAnimal The
choice oftest animal for lead bioavailability
in the young child should be one that
replicates or simulates as closely as possible
the various anatomic, physiologic, develop-
mental, and behavioral characteristics of
the lead-exposed infant or toddler. As
noted by Barnes and Dourson (88), the
U.S. EPA employs this rationale within a
policy that states that where data from sev-
eral animal systems are available, identifica-
tion should first be made of"...the animal
model most relevant to humans, based on
the most defensible biological rationale."
Some choices as test animal models of
childhood lead bioavailability are clearly
much better than others.
Gastrointestinal (GI) anatomy, physi-
ology, and developmental stage are signifi-
cant determinants of lead uptake in test
animals and humans. Those animal test
species whose GI tracts resemble as closely
as possible the GI tract ofthe young child
are therefore preferable for testing. Weis
and Lavelle (62) reviewed the relative
appropriateness of animal model selec-
tions for human lead bioavailability. They
noted that rodents and rabbits have the
gastric anatomy, food digestion physiol-
ogy, and feeding behaviors that make
them poor bioavailability surrogates for
young children. Mushak (12) and Weis
and Lavelle (62) also noted the necessity
of using animals at the developmental
stage that approximates the infant and
toddler in terms of increased absorption
oflead seen in the young child versus the
older child or the adult.
Rodents and rabbits evolved to process
plant material and this requires continuous
feeding as a behavior to sustain microbiotic
processing ofcellulosic material (62). This
constant feeding behavior also can sustain a
different pH than basal levels in the young
child (12). Gastric anatomy in the rodent
and rabbit matches the feeding behavior and
the processing ofa cellulose diet, and differs
greatly from that in other animal species and
the human child in terms of anatomical
configuration and the density ofgastric
acid-secreting cells. In the rodent, Weis and
LaVelle (62) noted that there is a very small
proportional stomach surface area associated
with acid secretion when compared to the
human stomach. Lead uptake occurs in cer-
tain segments of the small intestine (12).
The relative efficiency ofthe gut in various
animal species to absorb lead, compared to a
measure ofpotential lead intake rate such as
body surface area, would be a useful predic-
tor for enteric lead uptake rates (61,89).
Weis and LaVelle (62) showed a much
greater ratio ofgut absorptive surface to
body surface area for the human than for
the rat. This value is 108 for humans, com-
pared to 22 in the rat, about one-fifth the
ratio. This indicates that the relative effi-
ciency oflead uptake is 5-fold higher in
humans than in rats.
Rats and rabbits engage in coprophagy,
ingestion offeces, which can alter bioavail-
ability in several ways. Such recycling means
multipass uptake opportunities on one
hand, but also microbiotically transformed
fecal material that may bind lead differently
on the other. One can use fasted rats and
rabbits to attempt to minimize the constant
feeding. Coprophagy can be difficult to
control even ifappropriate cages are used.
Rodents and rabbits, as poor animal
models for infant and toddler lead bioavail-
ability, would be expected to show lower
absolute and relative lead bioavailability
than would be expected for the same mate-
rial in the human infant and toddler.
Infants and toddlers get their principal
nourishment via their major meals at inter-
mittent or scheduled feedings by their care-
givers, have a greatly different gastric
physiology and anatomy than the rodent
and the rat, and have other differences
noted above (12,62,90).
Despite these intrinsic problems with
rats and rabbits, various investigators have
still used these test species and have stated
reasons for their choices, reasons which
merit comment. For example, Freeman et
al. (91) chose the rat as the test surrogate
species for child lead bioavailability for
reasons that included the rat being a
commonly recommended species in various
compendia connected with contaminant
testing. However, these sources do not
address validity oflead bioavailability mod-
els or testing approaches per se, nor do they
address bioavailability. They are focused
mainly on general models of toxicity of
organic and inorganic contaminants, partic-
ularly models ofcarcinogenicity, a quite dif-
ferent area. Bioavailability affects toxic
responses, but the best models ofthe latter
are not necessarily the best models for the
former. A puzzling reason for the choice of
Freeman et al. is their assertion that the
young child and the rat are quite similar in
that both are continuous feeders with refer-
ence to their principal nutrition and there-
fore comparable as to physiology and
behavior for lead bioavailability. This state-
ment is patently incorrect, as can be readily
determined from numerous texts on pedi-
atric nutrition and gastroenterology, and the
comparative species assessment ofWeis and
LaVelle (62). The cited source ofthis incor-
rect statement by Freeman et al. (91) is
"Chaney, 1991" in the proceedings ofa lead
bioavailability symposium (92). The pub-
lished proceedings monograph available to
this author contains no single-author article
byChaney on this topic or anyother.
Use of a certain animal species for
quantifying lead bioavailability does not
assure a particular result. The variability
and uncertainties in lead uptake in soil
lead-dosed rodents can be seen in differing
results from three different reports ofsoil
surface-bound lead (rather than lead occur-
ring within the soil particle matrix itselfin
some geochemical form). Lead bound to
soil surfaces would simulate the very
common child lead exposure scenario of
lead fallout from atmospheric lead emis-
sions from some industrial source coming
into contact with nearby residential surface
soils. Freeman et al. (93) found that
bioavailability oflead from lead acetate
without control soil in diet was significantly
higher than when control soil was present,
indicating a soil suppression of uptake.
Lead sulfide, however, showed no such
reduction with soil present. Sheppard and
co-workers (94) found that use ofradiola-
beled soluble lead salt (nitrate) added to
feedwith and without added soil (5 or 20%
soil by feed weight) showed no statistically
significant effect ofthis diet soil loading on
lead uptake in mice fed for 30 days with
radiolabeled lead in soil-dosed feed mix.
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The authors were careful to note that
carcass total label and label concentrations
decreased as soil fraction increased, but this
was due to intake differences ofthe mixed
feed. When the radiolabeled content was
normalized for intake differences, no statis-
tically significant effect ofsoil on lead label
uptake was seen. Absence of an effect of
soil on lead uptake was reported by Dacre
and Ter Haar (87) in an earlier study of
lead-in-soil bioavailability using adult rats.
Soils fed for 30 or 90 days and that con-
tained lead associated with either atmos-
pheric fallout onto soil from auto exhaust
lead or paint lead deposition were com-
pared to equivalent diet loading with lead
acetate without soil. PbB levels among the
three groups were statistically indistin-
guishable at 30 days; at 90 days, PbB for
the soluble lead group was not given, but
the remaining two 90-day groups were not
statistically distinguishable.
Lead incorporated into geochemical
matrices has been reported to have lower
bioavailability when added to diet ofrats,
compared to acetate and other relatively
simple lead species (91,95,96). In the
study of Dieter et al. (96), using 6- to 7-
week-old rats, the geochemical lead was
contained in recently generated Alaskan ore
concentrate. Comparison lead species were
the acetate, oxide, and sulfide. At a diet
dosing of 100 ppm lead in all forms, the
lead ore PbB group was about 10% that of
the lead acetate group. Lead sulfide also had
less bioavailability than the acetate and
oxide. Freeman and co-workers (91,93,95)
studied soil lead bioavailability in variably
aged rats, with the lead-containing materi-
als including mining wastes. Both absolute
bioavailability (95) and relative bioavail-
ability, as a ratio with soluble lead acetate
reference (91), were tested, and were much
lower in soil-entrained lead than when sol-
uble lead salt was used. The absolute
bioavailability oflead salt indexed as PbB
was reported (95) as about 6-fold higher
than soil-encased lead-15% versus 2.7%.
Freeman et al. (93) also reported that resi-
dential soil-encased lead from a Colorado
extractive industry-impacted community
showed significantly less bioavailability
than soluble lead as the acetate salt.
Several studies have described the use
of rabbits in assessing lead bioavailability
from mining waste samples, despite the
considerable caveats about this species'
use in such investigations. The reports of
Ruby et al. (97) and Davis et al. (98)
describe feeding studies using 3-month-
old New Zealand white rabbits and
miningwaste material acutely administered
as a large, single bolus. Ruby et al. (96)
included time-serial PbB measurements
and the lead content ofvarious GI tract
fractions isolated over time, with the ani-
mals being dosed to provide information
on bioaccessibility, a recently coined term
for extent oflead solubilization from some
medium into human or animal gastric
fluid, or simulations thereof. This term
has not yet been generally accepted by the
toxicology community nor fully character-
ized as to validity. The term provides no
direct measure of bioavailability, but is
linked to it. Ruby et al. (97) reported that
the measured soluble fraction of mine
waste bolus lead in rabbit GI tract is
markedly lower than that for lead given as
the acetate salt. This study has been widely
cited by the authors and others as a reli-
able animal model of lead bioavailability
from extractive-industry wastes and it is
important that the study be examined
carefully and in some detail.
There are quite a few technical and
interpretive problems with Ruby et al.
(97) that greatly limit applicability oftheir
results for bioavailability conclusions
applicable to humans. This report does
provide information consistent with the
broad experimental caveat that rabbits are
poor animal models oflead bioavailability
in preschool children and poor animal cali-
brators for subsequent in vitro screening of
geochemical lead media. Flaws include
incomplete and incorrect time-point
studies oflead uptake, mine waste groups
being tested differently than the lead
acetate group, and both being evaluated as
isolated lead concentration points and as
concentration ratios to the reference data
point, rather than use ofthe preferred, uni-
versally employed technique ofAUC mea-
surements. The AUC method would be
required because lead uptake to blood from
the mine waste material was rising signifi-
cantly throughout the testing time (36 hr)
and likely beyond it. At the end of 36 hr,
waste material-dosed rabbits showed PbB
content 4-fold higher than at 1 hr, the sole
testing point for the reference acetate dose.
These authors used these incorrectly
obtained ratios to calculate in vivo solubi-
lization oflead in the rabbit gut and from
these estimates, proportional bioavailabil-
ity as well. One cannot retrospectively
attempt AUC calculations with these
published data and reestimate solubilization
and relative uptake, as only one data
point, at 1 hr, exists for the critical acetate
reference group.
Additional areas oftesting and interpre-
tation difficulty with Ruby et al. (97)
include a) a mass balance analysis carried
out by the present author that showed that
much ofthe starting lead dose administered
to the various groups cannot be accounted
for by any biokinetically likely means,
b) unacceptably low solubility of lead
acetate in the stomach ofthese rabbits, and
c) use ofa swamping bolus oflead-contain-
ing material that is qualitatively and quanti-
tatively irrelevant to typical children's
soil/dust ingestion behaviors.
The present author's mass balance
analysis for lead in the Ruby et al. (96)
rabbit study, using Table III of Ruby et
al., showed that the fraction of starting
lead dose appearing in rabbit GI tract con-
tents, i.e., soluble and solid fractions of
lumen contents, summed over stomach,
small intestine, and large intestine, is sig-
nificantly less than the dosing level, and
the shortfall occurs over the 6 hr of com-
plete necropsy-group testing. At 3 hr,
60%, and at 6 hr, 91% of the 16.4-mg
starting dose cannot be accounted for in
collected GI tract contents. These declines
occur with increases in total PbB content.
The 1-hr time point for lead acetate shows
60% unaccounted for. Over these short
time points, lead loss via fecal excretion
would not account for the shortfall. It is
plausible that only partial collection ofGI
tract contents occurred or that much of
the missing lead had been transported to
intestinal mucosa epithelium. Ifthe latter,
the resulting high ratio of enteric tissue
lead to reported PbB would be extremely
high, relative to what one typically sees in
such distribution data. The time course of
lead uptake in these rabbits was apparently
far from complete, and would likely pro-
duce a much higher estimate of lead
bioavailability with a longer testing time
frame. Ruby et al. (97) did not analyze GI
tract tissue, nor internal organs including
bone, for lead levels. Deposition of the
missing lead in internal organs would
show uptake, but would arguably require
higher PbB content than that reported by
these authors. Table III ofRuby et al. (97)
shows only 37% solubility for the soluble
lead species employed, the acetate salt.
This percentage is half that for the com-
panion in vitro simulation and about one-
third of expected 100% solubility. The
authors suggest lead binding to retained
animal chow, but the data in their Figure
2 do not support this assumption.
Finally, the Ruby et al. (97) study uses
a mass ofmatrix, 4.2 g (2-g lead sample/kg,
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2.1 kg weight) given as a single dose, a
route ofdosing that is totally inappropriate
for any comparisons with childhood daily
ingestion rates, as described in a later sec-
tion. Although Ruby et al. based this
administration rate on a 10-g soil intake in
a pica child, this quantity for a pica child is
itself quite suspect. Furthermore, the typi-
cal child engaging in mouthing activity is
only ingesting 100 to 200 mg soil/dust,
and doing so over the entire play period as
noted later.
The above reanalysis indicates that lead
uptake from the mining waste materials in
the rabbits used in Ruby et al. may have
been more than their reported data would
indicate. In addition, use of the rabbit
model by Ruby et al. (97) for calibrating
an in vitro approach also described in that
paper is untenable for application to child
lead bioavailability from these materials.
Kierski (75) showed that soil Pb is
relatively less bioavailable than lead acetate
in 5-week-old rabbits when large amounts
ofsoil are given, but when soil quantities
more relevant to child intakes are used, the
relative absorption increased to 55 to 90%
ofthe reference acetate uptake.
Swine appear to be much better test
surrogates for lead bioavailability from geo-
chemical substances for the infant and tod-
dler on general anatomic, physiologic, and
behavioral grounds, in contrast to the many
problems with use of rats and rabbits. A
number ofstudies have been carried out by
various academic researchers and U.S. EPA
Region VIII toxicologists using weanling
swine. U.S. EPA Region VIII includes
Utah, Montana, North Dakota, South
Dakota, Colorado, and Wyoming, all states
with concerns about potential exposures to
mining wastes. Relative and absolute
bioavailability of lead in a geostatistically
broad range ofsubstances associated with
extractive industry waste sites can be
demonstrated and in many cases can be sig-
nificant when using the weanling swine
model (79-82,90,99). Studies with the
young swine have involved both acute and
subacute dosings, detailed biokinetic and
toxicologic analyses, and provision made
for availability of all the original data to
others (79-82).
Table 1 summarizes absolute and relative
bioavailability of lead in the young swine
model of these investigators as reported in
Casteel et al. (79-82,90) along with rat and
rabbit data described earlier. The percent-
ages for the young swine were calculated by
the authors mainly from PbB but with some
limited weighting for other tissues. As noted
above, PbB is the most practical and easily
comprehended index for lead bioavailability.
These reports cover four different smelter
and mixed extractive industry waste sites in
the United States. The range of sample
types studied by Region VIII toxicologists
and their colleagues are geostatistically more
representative ofthe expected significant
sample heterogeneity at sites of this type
than the limited samplings described in
other studies.
Relative and absolute bioavailability
were both calculated. Relative bioavailabil-
ity is calculated relative to a soluble lead
salt and absolute bioavailability is calcu-
lated assuming 50% uptake for soluble lead
in children's diets. Use of the 50% figure
from infants and toddlers ingesting soluble
lead in their diet for extrapolation to the
young swine assumes that the uptake rate is
similar across species.
Table 1 shows thatfor a range ofdifferent
Superfund site lead-contaminated samples,
the absolute bioavailability of lead in
young swine ranges from 27 to 40%.
These values are comparable to the default
lead bioavailability value for soil and dust
used in the U.S. EPA IEUBK model
(30%). The Murray, Utah, slag sample
bioavailability value of 27% is consistent
with its micromineralogy showing that
proportionately more ofthe lead species in
the sample is in the form of nonvitreous
lead species, including lead oxide. The
oxide would have higher bioavailability.
This particular finding with slag makes it
clear one cannot draw general conclusions
about likely lead bioavailability by the
superficiality of general classification, e.g.,
slags, without tandem animal and miner-
alogical or chemical speciation assessment.
The study design for the swine model
entails 15-day dosing, which corresponds
to a pre-steady-state dosing regimen but a
time period adequate to establish relative
bioavailability using soluble lead dosings
in one of the groups. Half-doses were
administered at two times daily, to produce
less of a bolus effect and to more closely
resemble intermittent child oral activity
patterns. Amounts of lead-containing
matrix, e.g., soils, in the daily dose were
administered to provide multiple dosing
levels per kilogram animal weight. In the
Table 1. Absolute and relativea bioavailability or gastric solubility of lead in various media administered to test
animals.
% Bioavailability
Test species Sample source Absolute Relative Reference
Weanling swine Aspen, Colorado, 31 (soil) 58 Casteel et al. (90)
residential soil 30 (waste) 56
orwaste pile
Weanling swine Palmerton, Pennsylvania, 34 (soil 2) 67 Casteel et al. (81)
soil samples 27 (soil 4) 54
Weanling swine Murray, Utah, 36 (soil) 71 Casteel et al. (80)
slag, soil composites 27 (slag) 53
Weanling swine Jasper, Missouri, 29 (high smelter) 58 Casteel et al. (79)
three smelter sites 40(high mill) 79
40 (low mill) 80
Rabbits Five roadside 56-67 Kierski (75)
(5 weeks old) soils with Pb 55-90
(lower amounts
of soil)
Rats Butte, Montana, 20 Freeman et al. (91)
mine waste
Rats Butte, Montana, 3 Freeman et al. (95)
mine waste
Rats Leadville, Colorado, -1 -7 Freeman et al. (93)
NPL site soils
Pb acetate 14
High Pb acetate
+ control soils -4
% Gastric solubility
Rabbits Mine waste 1-6 10 Ruby etal.(97)
(3 months old)
&Relative to Pb acetate.
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1997 report of Casteel et al. (90), 8-kg
young swine received doses of75, 225, and
675 pg/kg bw.
Comparison ofrelative bioavailabilities,
i.e., soil or other matrix lead uptake versus
the acetate salt as soluble reference across
the three species in Table 1 indicates that
not only do absolute bioavailabilities differ
in going from rats and rabbits to swine, but
so do relative bioavailabilities, where the
acetate is used.
Other factors come into play besides
surrogate animal species selection in
studies oflead bioavailability, particularly
as these factors relate to calibrating the
U.S. EPA IEUBK model. The various ani-
mal model studies published so far differ
in the developmental stage of the animal
used, the dosing regimens, and the geosta-
tistical representativeness of the sample
types analyzed.
Selection ofa Similar Developmental
Stage, Animal versus Child. The infant
and toddler are at an early stage of
physiologic and physical development and
absorb lead at a higher rate than adults.
Consequently, the validity ofany surrogate
animal model for human lead bioavailabil-
ity requires matching developmental stages
ofthe test animals as closely as possible to
those for human infants and toddlers. Lead
bioavailability data derived from adult
animals with their much lower lead uptake
compared to young animals or human
infants and toddlers may greatly underesti-
mate extrapolated lead uptake from the
medium, certainly for absolute bioavailabil-
ities but perhaps for relative bioavailabilities
as well. Rats show high lead uptake and
retention, about 50%, in the nursing stage,
but revert rapidly to adult lead uptake
rates at weaning. Forbes and Reina (71)
recorded lead uptake rate versus rat pup age
at multiple time points and showed that
rats are close to the adult uptake rate several
days after weaning. This means that use of
rats about 26 days or older results in adult
lead uptake data. Kierski (75) showed that
5-week-old weanlings had higher lead
uptake than older rabbits.
The bioavailability studies ofFreeman et
al. (91,93,95) using the rat involved
animals whose GI tracts were essentially
mature, i.e., associated with much lower
lead uptake. Animals were either 49 to 56
days old or were 28 days old at the start of
the feeding studies, all beyond weaning
(about 26 days). The 28-day-old animals
would be at, or arrive at, adult uptake rates
shortly into the dosing regimen, up to 44
days. Uptake rates for lead in any medium
in these studies would be appropriate only
for adult lead uptake rates, not those of
infants and toddlers, and direct comparisons
would underestimate those uptakes that
would be operative in children.
Young swine used in the studies
described above (90) were at the juvenile
stage, 5 to 6 weeks old. In swine, weaning
occurs at about 3 weeks. The somatic matu-
ration process in the swine is much slower
(62) and puberty is reached much later on
the absolute timescale than in rats. This may
include physiologic maturation ofthe GI
tract. Although the precise quantitative rela-
tionship ofyoung swine development to
enteric lead uptake has not been determined,
we expect that the lead uptake rates in those
weanling swine studied so far would be
greater than the adult uptake rates Freeman
et al. encountered for lead bioavailability.
With rabbits, Ruby et al. (97) were using
postweanling animals with reduced lead
uptake compared to rabbits at 5 weeks or
younger asstudiedbyKierski (75).
Child Soil/Dust Ingestion Rates
versus Animal Dosing Protocols. The
typical late infant or toddler, i.e., one who
does not display pica, ingests very small
quantities of soils and dusts via normal
mouthing activity and does so through the
course ofa day, based on data noted below.
Cumulative daily ingestion ofsoil and dust
in such children is about 100 mg or higher,
based on various sources (e.g., 12,26,100)
including more recent studies ofCalabrese
and Stanek (101,102) cited below. The
U.S. EPA IEUBK model uses a figure of
135 mg/day for late infants and toddlers.
Such gustatory behavior assures that there is
not a huge bolus oflead or soil ingested at
one time. This also means that there is no
overwhelming ofthe typical biochemical
and physiologic mechanisms that are
brought into play to deal with ingested
material. This enteric apparatus includes
basal acidity ofthe stomach, adequate addi-
tional acid secretion via stimulation, lead
chelating or other binding processes, all
working to leach lead from dust and soil
particles during their flow in milligram
amounts through the GI tract. Brunekreef
et al. (100) noted the typical infant and
toddler oral exploratory behaviors that sup-
port repetitive mouthing behaviors that are
consistent with continuous ingestion by
these children ofsmall amounts ofdust and
soil over the course of a play period, ulti-
matelyadding up to adaily intake of 100 to
200 mg. Child hand-wipe lead analyses of
Que Hee et al. (13), Duggan et al. (14),
and the three participants in the U.S. EPA
soil lead abatement demonstration project,
as summarized in the U.S. EPA integrated
report of this project (18), report finding
relatively small amounts oflead, and associ-
ated dust and soil containing that lead, on
children's hands when tested at typical play
times. Therefore, only small amounts of
dust and soil carrying these small lead
quantities are present on children's hands at
one time. These data support continuous
consumption ofdust and soil by children
through normal mouthing activity, and do
not support any likelihood that children
ingest 100 to 200 mg ofsoil/dust only as a
single bolus during a typical dayat play.
The amounts ofsoil and dust ingested
by children daily is discussed and studied in
some recent systematic estimates of inges-
tion by Stanek and Calabrese (101) and
Calabrese and Stanek (102). Calabrese and
Stanek (102) summarized their quantitative
estimates ofsoil ingestion by children as
determined using different elemental trac-
ers. These workers adjusted intake data
from each tracer for tracer-specific errors in
mean estimates from daily or weekly obser-
vations. The combined tracer mean is 139
mg/day, almost midway between the 100 to
200 mg range commonly taken as daily
child dust and soil intake. The value is vir-
tually identical to the default values for late
infant and toddler age bands in the U.S.
EPA biokinetic model.
Pica is the extreme, abnormal expression
of normal child mouthing activity and
entails ingestion ofboth larger amounts of
soils and dusts than normal and the inges-
tion ofa wide range ofother nonfood items
(23). The excessive ingestion ofsoil in chil-
dren with pica, based on available literature,
is not known to occur only once daily, as
implied in some ofthe studies noted earlier,
nor would we expect it to. Rather, such ele-
vated ingestion continues throughout the
child's waking day. Therefore, pica children
defined as such byeitherclinical orepidemi-
ologic criteria would arguably not have their
GI tracts and any associated enteric
processes overwhelmed by single, large soil
boluses. By contrast, the Ruby et al. rabbit
study (97) and the Freeman et al. studies in
rats (91) employed large, swamping
boluses, relative to animal body weight and
relative to the character of children's soil
ingestion. These workers used a soil pica
intake of 10 g in children for developing
their rat and rabbit soil lead dosing regi-
mens, respectively, citing information in
Kimbrough et al. (103) and Calabrese et al.
(104). Kimbrough et al. (103) do not
identify 10 g as an actual pica level, and this
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paper does not even discuss pica children.
The 10-g figure is an obsolete value used by
Kimbrough et al. to depict a normal intake,
compared to the current accepted intakes of
100 to 200 mg. Calabrese et al. (104) only
cited the Kimbrough et al. figure without
confirmation. One Stanek and Calabrese
definition ofchild geophagia is a statistical
one of children at the 95th percentile in
ingestion rate, corresponding to a mean of
1.75 g daily soil intake. Calabrese et al.
(105) report one child had excessive soil
intake, 5 to 7 g/day, during one time seg-
ment in their study. They note that this sin-
gle case was the only one in their study and
in three others, a total of517 children. This
is a 0.2% prevalence rate for children at or
near this ingestion level. Stanek and
Calabrese (101) also estimate that in a typi-
cal infant and toddler year, only one-third
ofchildren would ingest as much as 10 g of
soil for no more than one day orso peryear.
Kierski (75) showed the effect of
swamping amounts ofsoil mass in affecting
lead uptake in veryyoung rabbits. When soil
mass was reduced, soil lead uptake versus
leadacetate uptake increasedsignificandy.
In this regard, it is instructive to compare
the amounts ofthe lead-containing medium
given the swine in the dosing regimen of
Casteel et al. (90) to that given rabbits by
Ruby et al. (97), as both reports used leaded
matrix material having about 3900 ppm
lead. For the residential soil listed as having
3870 ppm lead in the Casteel et al. report,
the amount ofsoil administered at the 225
pg/kg bw dose to the 8-kg swine (-1800 pg
total lead) was about 0.5 g/animal or about
62.5 mg/kg bw. This dose is given at two
time points, one-halfat each point. This is
0.25 g/animal or 31.3 mg/kg bw at any one
time. This can be compared to the Ruby et
al. (97) single bolus administration to rab-
bits ofa composited mine waste, having a
final concentration of3900 ppm lead, at 2
g/kg bw, or 4.2 g mine waste/animal. On a
daily body weight dosing basis, ratios of
swine/rabbit matrix quantities are quite
small-0.031. That is, rabbits received
about 30-fold more matrix, and 60-fold
more matrix on a split-dose basis (0.031/2)
to then swamp the animal gut and absorp-
tive apparatus (see above), a factor not oper-
atingwith the swine.
In Vitro Simulation of Lead
Bioavailability in Vivo. A number of
studies have described in vitro approaches
to either lead bioavailability or parameters
involved in lead bioavailability. The earlier
information was discussed and critiqued by
Mushak (12). Such approaches as testing
simple solubility do not accord well with
overall human lead uptake and subsequent
lead poisoning. Lead sulfide, for example,
has low solubility but when used in prepa-
rations used by humans, lead poisoning
can occur, including when used as an eye
cosmetic for Indian and Middle Eastern
women and children (12).
Limitations in in vitro approaches are
many. First, the human GI tract is difficult
to closely simulate as to lead uptake for
thermodynamic, biochemical, and physico-
chemical reasons. The gut is a thermody-
namically open system, where uptake by
intestinal microvilli during gut transit pro-
duces equilibria shifts, with such shifts
throughout the gut mixtures leading to
ongoing dissolution. No evidence exists to
show such equilibria shifts would not estab-
lish themselves in animal systems, and in
fact would be expected to occur very
rapidly. Current published in vitro test sys-
tems, by contrast, are still closed systems
thermodynamically. In vitro systems test
solubility or bioaccessibility, but lead can
enter the gut wall in ways other than initial
dissolution, e.g., in micelles and as fine sus-
pensions. This is ofspecial concern in the
infant. Use ofbiochemical mixes of, e.g.,
organic acids in isolation from the stomach
and intestines creates problems as to their
effectivenesswithout the full in vivomilieu.
Mindful of these caveats, several
investigators have attempted to provide a
closer simulation of in vivo lead uptake
processes for screening purposes by focus-
ing on one parameter, simulated solubiliza-
tion in the stomach and retention of the
solubilized fraction during passage through
portions ofthe small intestine where lead is
known to be absorbed (12). Ruby et al.
(97,106) have reported an in vitro model
claimed to be validated with the rabbit
(97) and some earlier rat data. The
described problems with the rabbit study
of Ruby et al. (97) for both in vivo and
in vitro use raise serious questions about
the in vitro test described.
The studies of Drexler and colleagues
(107-110) entail a simulation of in vivo
lead bioavailability data from numerous
studies involving the young swine surro-
gate described above. Estimations ofbioac-
cessibility are compared to the in vivo
bioavailability data.
The relative and absolute estimates
in the in vitro method generally accord
in both absolute and relative solubiliza-
tion percentage with a variety of selected
extractive industry wastes from former
milling, smelting, mining, and mixed sites.
This approach is still in development and
additional testing is under way. The
Drexler approach also has an evolving
quick test version that entails trimming
some of the experimental steps simulating
intestinal uptake described by Drexler
(110) in a workshop presentation on
bioavailability held in December 1997.
This variation on the Drexler method was
summarized in comments made at this
same workshop by Ruby (111). Consid-
erable multilaboratory evaluation using
many more representative samples will be
required before in vitro screening is placed
on a reliable footing regarding its predictive
power for in vivobioavailability.
Summary and Conclusions
Empirical data used in human lead exposure
assessment are typically experimental or
observational, i.e., epidemiologic in nature.
Experimental studies have been carried out
in diverse experimental animals and occa-
sionally in human adults. Epidemiologic
data have described effects of lead in
occupationally exposed workers or toxic
impacts in segments of the general popu-
lation such as preschool children and
fetuses through lead intakes by pregnant
women. Lead exposures in humans can be
potential or actual. The former is typified
by environmental monitoring of the lead
content of various media that serve as
pathways for lead contact. Actual lead
exposure is established by biologic moni-
toring, typically carried out by using either
biomarkers of lead exposure such as PbB,
or measurements of early effect. This
paper emphasizes exposure biomarkers.
Each form of monitoring has its
advantages and drawbacks, and these are
examined in detail in this paper. For exam-
ple, environmental testing reveals which of
various possible leadsources actuallyprovide
significant exposures in a specific case. Lead
sources provide the independent variable in
inferential statistical techniques that link
source to a biomarker such as PbB. Biologic
monitoring ofhuman lead exposure, e.g.,
PbB data, indicates the extent to which
actual lead intake and uptake has occurred.
Furthermore, such exposures can define
some lead poisoning risk classification or
can be employed as part ofthe data base for
medical intervention or management of
individual poisoningcases.
This paper presents the uses and limits
ofempirical data in the evaluation ofpre-
dictive models of human lead exposure,
mainly biokinetic or mechanistic models.
These models generate PbB estimates that
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offer the risk assessor or risk manager
assistance in evaluating the nature and
extent oflead's potential adverse impacts in
exposed communities. A particular focus
was the U.S. EPA IEUBK biokinetic
model, used to estimate childhood lead
exposure. This model is the most heavily
validated and calibrated ofthe several bioki-
netic models now ofinterest in the lead risk
assessment community. These models,
when used correctly with appropriate
empirical data inputs, additionally possess
the flexibility to a) ascertain historic expo-
sures via dose reconstruction from current
environmental data, b) estimate results of
some regulatory intervention, e.g., pre-
dicted PbB responses to soil lead abate-
ment, and c) ascertain the consequences of
future land use options in and around a
lead-contaminated site, in terms ofresulting
PbB concentrations.
This paper points out, with supporting
information, that one must be very careful
in the use of measurement data for either
evaluating or challenging the outputs, i.e.,
exposure estimates, ofsuch predictive mod-
els. A number ofspecific points were made
about potential pitfalls in the use of PbB
levels either separate from or in tandem with
modeling efforts. The paper noted various
criteria that define more reliable forms of
PbB data, for use in assessment and model-
ing community lead exposures: a) the use of
serial versus single-shot PbB measurements;
and, where serial measures are not feasible,
b) the absence oftemporal and structural
artifacts that would reduce the reliability of
PbB data, confounders that include public
awareness and concerns ofchild caregivers
that result in abrupt, transitory reduction in
PbB; c) use ofan appropriate biostatistical
and epidemiologic design that does not
obscure the prevalence oftoxic lead expo-
sures in those segments ofthe study popula-
tion at particular risk; and d) PbB data that
provide reliable and accurate links to those
environmental lead sources that produce the
significant lead exposures.
Predictive, biokinetic models of lead
exposure in high-risk groups rarely come
equipped with all the best selections for
inputs and outputs for a particular site
and require a certain level ofsite-specific
information. One significant biokinetic
component ofany lead model input is the
lead uptake rate or bioavailability, espe-
cially in the GI tract. This paper provides
a fairly detailed discussion ofbioavailabil-
ity, a growing but often misunderstood or
misused topic in the lead area. Discussion
includes various approaches for determin-
ing this parameter in clean, physiologic
terms, i.e., experimental animal models of
lead bioavailability in human infants and
toddlers. Such models avoid many of the
problems oflooking at human populations
directly. The article shows that rodents
and rabbits are not particularly good mod-
els of lead uptake in the infant and tod-
dler, especially under conditions actually
reported in published work. Published
work using rats and rabbits produced data
that are problematic on added grounds.
Lead-dosing methods included those that
have little relevance to typical childhood
oral lead exposures. To date, young swine
appear to be the best test model
Many simple, in vitro approaches have
been reported over the years, in the quest to
avoid the expense and complexity ofin vivo
testing. This paper presents some of the
current approaches, but cautions that there
are many limits to such approaches. This
especially applies where simple gastric solu-
bilization is deemed an adequate surrogate
for lead bioavailability in humans. Current
efforts do mark some improvement over
crude solubility testing in simple aqueous
solutions. Simplified, inexpensive screening
approaches that do not reflect, or, worse,
underestimate actual human bioavailability
are not scientifically appropriate substitutes
for valid animal models. Conceptually,
comparison problems with in vitro versus
in vivo approaches do not arise for those
media in which lead is readily mobilizable,
based on chemical speciation or micromin-
eralogical grounds. They arise when one
sees a low lead solubilization rate in an in
vitro screening. Would the in vivo test of
that same lead-containing substance show a
similar rate or does the linkage become
disconnected? A related question would be
how many representative samples will
provide an adequate statistical comfort level
for universal use of in vitro testing at any
and all sites.
Finally, lead bioavailability has to be put
into quantitative toxicologic context. That
is, one cannot equate lead bioavailability to
a specific net toxic risk in isolation. This is
simply because the total amount of lead
entering the bloodstream from the GI tract
per unit time is the product ofbioavailabil-
ity multiplied by lead concentration in some
ingested substance. An intrinsic bioavailabil-
ity of 100% for a lead species that is not
present in the exposure medium does not
result in lead poisoning or risk of lead
poisoning. For media with variable lead
content and in different geochemical/for-
mulary forms, comparisons must be more
closely drawn. A bioavailability of 10% for a
lead species occurring at a concentration of
2000 ppm in 100 mg ofingested matrix is
no less toxic than a lead species that is 100%
bioavailable from 100 mgofa matrix having
200 ppm lead. Lead at an extremely low
bioavailability of 1% is equally toxic under
the above conditions at a lead concentration
of20,000 ppm.
There has been a simplistic tendency in
some regulatory areas and the recent risk
assessment literature to confuse compara-
tive statements oflead bioavailability with
net toxicologic rankings. For example, min-
ing waste lead is held by some to always be
less bioavailable than lead from urban street
dust. That is partly true, and in certain situ-
ations. That is not equivalent to saying that
miningwaste is not toxic to children. It also
does not say that there are no risks to chil-
dren who come in contact with this mater-
ial. The above trio of bioavailability
comparisons voids this premise. The fallacy
ofthe assumption can be understood when
we consider that ore mill tailings and
weathering smelter slags can contain lead at
many thousands of parts per million.
Children ingesting 100 to 200 mg ofsuch
material with 20,000 ppm lead and a low
lead form bioavailability of 5% are still at
high risk for lead poisoning.
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